Evidence map›Paper›PMID 42274710›Full record

ArticleNanomaterials (Basel, Switzerland)2026

Correction: Barani et al. Nanomaterials in the Management of Gram-Negative Bacterial Infections.

Mahmood Barani, Mahira Zeeshan, Davood Kalantar-Neyestanaki, Muhammad Asim Farooq, Abbas Rahdar, Niraj Kumar Jha, Saman Sargazi, Piyush Kumar Gupta, Vijay Kumar Thakur

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Mahmood BaraniMedical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman 7616913555, Iran.ORCID 0000-0002-1711-2522
Mahira ZeeshanDepartment of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan.ORCID 0000-0002-3539-7971
Davood Kalantar-NeyestanakiMedical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman 7616913555, Iran.
Muhammad Asim FarooqFaculty of Pharmacy, Department of Pharmaceutics, The University of Lahore, Lahore 54000, Pakistan.ORCID 0000-0002-4569-2317
Abbas RahdarDepartment of Physics, University of Zabol, Zabol 9861335856, Iran.ORCID 0000-0003-4766-9214
Niraj Kumar JhaDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida 201310, India.ORCID 0000-0001-9486-4069
Saman SargaziCellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan 9816743463, Iran.ORCID 0000-0002-2255-5977
Piyush Kumar GuptaDepartment of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida 201310, India.ORCID 0000-0002-3346-910X
Vijay Kumar ThakurBiorefining and Advanced Materials Research Center, SRUC, Edinburgh EH9 3JG, UK.ORCID 0000-0002-0790-2264

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID42274710
PMCPMC13258376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.